TNDM

28.76

5.19% 1.42

Handel nachbörslich: 28.51 -0.25 -0.87%

Tandem Diabetes Care Inc (TNDM)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TNDM? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$27.34

Offen:

$27.15

24-Stunden-Volumen:

1.42M

Relative Volume:

1.11

Marktkapitalisierung:

$1.87B

Einnahmen:

$796.00M

Nettoeinkommen (Verlust:

$-136.49M

KGV:

-8.904

EPS:

-3.23

Netto-Cashflow:

$-64.24M

1W Leistung:

-8.32%

1M Leistung:

-18.62%

6M Leistung:

-39.20%

1J Leistung:

+61.66%

1-Tages-Spanne:

$27.15

$29.27

1-Wochen-Bereich:

$27.15

$31.75

52-Wochen-Spanne:

$17.33

$53.69

Tandem Diabetes Care Inc Stock (TNDM) Company Profile

Firmenname

Tandem Diabetes Care Inc

Sektor

Healthcare (1196)

Branche

Medical Devices (153)

Telefon

858-366-6900

Adresse

12400 HIGH BLUFF DRIVE, San Diego, CA

Mitarbeiter

2,400

Twitter

@tandemdiabetes

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

TNDM's Discussions on Twitter

Vergleichen Sie TNDM mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TNDM	28.76	1.87B	796.00M	-136.49M	-64.24M	-3.23
ABT	117.36	202.64B	41.22B	5.77B	6.49B	2.94
SYK	389.40	150.72B	21.97B	3.59B	3.21B	6.74
BSX	90.45	133.82B	15.91B	1.79B	1.89B	0.82
MDT	87.59	112.98B	32.58B	3.93B	5.15B	2.71
EW	69.89	40.52B	6.60B	4.16B	490.10M	2.34

Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-08-04	Herabstufung	Citigroup	Buy → Neutral
2023-05-05	Herabstufung	BofA Securities	Neutral → Underperform
2023-04-24	Herabstufung	Raymond James	Outperform → Mkt Perform
2023-03-29	Eingeleitet	UBS	Neutral
2023-01-26	Eingeleitet	Wolfe Research	Peer Perform
2022-11-15	Hochstufung	Wells Fargo	Underweight → Equal Weight
2022-10-18	Eingeleitet	Barclays	Overweight
2022-10-12	Eingeleitet	Jefferies	Buy
2022-08-09	Herabstufung	Wells Fargo	Overweight → Underweight
2022-03-02	Fortgesetzt	BofA Securities	Neutral
2022-01-19	Hochstufung	Wells Fargo	Equal Weight → Overweight
2021-07-21	Fortgesetzt	Cowen	Outperform
2021-05-25	Eingeleitet	Barclays	Underweight
2020-12-15	Herabstufung	Wells Fargo	Overweight → Equal Weight
2020-08-20	Eingeleitet	Wells Fargo	Overweight
2020-07-31	Hochstufung	Guggenheim	Neutral → Buy
2020-07-06	Hochstufung	Citigroup	Neutral → Buy
2020-06-18	Bestätigt	Raymond James	Outperform
2020-04-24	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2020-03-23	Herabstufung	Guggenheim	Buy → Neutral
2020-03-05	Eingeleitet	Citigroup	Neutral
2020-02-06	Eingeleitet	Raymond James	Outperform
2020-02-04	Herabstufung	Robert W. Baird	Outperform → Neutral
2019-10-18	Eingeleitet	Guggenheim	Buy
2019-10-04	Hochstufung	UBS	Neutral → Buy
2019-05-17	Bestätigt	BofA/Merrill	Neutral
2019-05-13	Eingeleitet	SVB Leerink	Outperform
2019-03-08	Eingeleitet	BMO Capital Markets	Outperform
2019-03-05	Bestätigt	BofA/Merrill	Neutral
2019-02-27	Bestätigt	Lake Street	Buy
2018-11-21	Hochstufung	Robert W. Baird	Neutral → Outperform
2018-09-26	Bestätigt	Dougherty & Company	Buy
2018-09-26	Bestätigt	Piper Jaffray	Overweight

Alle ansehen

Tandem Diabetes Care Inc Aktie (TNDM) Neueste Nachrichten

04:26 AM

Victory Capital Management Inc. Has $24.91 Million Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat

04:26 AM

Nov 16, 2024

Slammed 27% Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Screens Well Here But There Might Be A Catch - Simply Wall St

Nov 16, 2024

Principal Financial Group Inc. Has $15.71 Million Stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat

Nov 16, 2024

Nov 15, 2024

(TNDM) Proactive Strategies - Stock Traders Daily

Nov 15, 2024

Simplify Asset Management Inc. Acquires New Stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat

Nov 15, 2024

Nov 14, 2024

Diabetes Devices Drugs Market Overall Study Report 2024-2032 | - openPR

Nov 14, 2024

Insulin Infusion Pumps Market Size, Share, Outlook, Industry - openPR

Nov 14, 2024

Nov 13, 2024

Tandem Diabetes Care's SWOT analysis: insulin pump maker's stock faces growth hurdles - Investing.com Canada

Nov 13, 2024

Nov 12, 2024

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 12, 2024

Nov 11, 2024

Lisanti Capital Growth LLC Decreases Stock Holdings in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat

Nov 11, 2024

Leerink Partnrs Has Negative Outlook of TNDM FY2024 Earnings - MarketBeat

Nov 11, 2024

Nov 09, 2024

Tandem Diabetes Care (NASDAQ:TNDM) Shares Down 9.6% Following Analyst Downgrade - MarketBeat

Nov 09, 2024

Tandem Diabetes Care (NASDAQ:TNDM) Issues Quarterly Earnings Results - MarketBeat

Nov 09, 2024

Nov 08, 2024

Oversold Conditions For Tandem Diabetes Care (TNDM) - Nasdaq

Nov 08, 2024

Barclays Forecasts Strong Price Appreciation for Tandem Diabetes Care (NASDAQ:TNDM) Stock - MarketBeat

Nov 08, 2024

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024

TNDM Q3 Earnings Beat, '24 Sales View Up, Stock Falls in Aftermarket - Yahoo Finance

Nov 08, 2024

Tandem Diabetes price target lowered to $37 from $39 at Baird - Yahoo Finance

Nov 08, 2024

Tandem Diabetes Care Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 08, 2024

Analyst Estimates: Here's What Brokers Think Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) After Its Third-Quarter Report - Yahoo Finance

Nov 08, 2024

Nov 07, 2024

Tandem Diabetes Care (NASDAQ:TNDM) Price Target Lowered to $56.00 at Canaccord Genuity Group - MarketBeat

Nov 07, 2024

Robert W. Baird Cuts Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $37.00 - MarketBeat

Nov 07, 2024